BH Tang, XF Zhang, SM Fu, BF Yao, W Zhang… - Clinical …, 2024 - Springer
Introduction Isoniazid is a first-line antituberculosis agent with high variability, which would
profit from individualized dosing. Concentrations of isoniazid at 2 h (C2h), as an indicator of …